Yuyu Pharma (000220) — Capital Reinvestment Ratio
Latest as of September 2025:
1.75x
Yuyu Pharma (000220) has a Capital Reinvestment Ratio of 1.75x as of September 2025, meaning it reinvests 2% of its operating cash flow (₩836.62 Million) in capital expenditures (₩1.46 Billion). See Yuyu Pharma (000220) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.75x
Capex / Operating Cash Flow
Operating Cash Flow
₩836.62 Million
KRW
Capital Expenditures
₩1.46 Billion
KRW
Data as of
Sep 2025
Most recent filing
Yuyu Pharma Capital Reinvestment Ratio (2011–2024)
This chart tracks Yuyu Pharma's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Yuyu Pharma (2011–2024)
Year-by-year Capital Reinvestment Ratio for Yuyu Pharma from 2011 to 2024. For live market cap and broader valuation context, see 000220 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.6% |
| 2023 | 12.13x | ₩420.86 Million | ₩5.11 Billion | ▲ +800.7% |
| 2021 | 1.35x | ₩4.51 Billion | ₩6.07 Billion | ▲ +120.5% |
| 2019 | 0.61x | ₩13.19 Billion | ₩8.06 Billion | ▼ -61.8% |
| 2018 | 1.60x | ₩6.11 Billion | ₩9.76 Billion | ▼ -82.7% |
| 2017 | 9.25x | ₩561.35 Million | ₩5.19 Billion | ▲ +3819.4% |
| 2016 | 0.24x | ₩9.82 Billion | ₩2.32 Billion | ▼ -20.4% |
| 2014 | 0.30x | ₩1.36 Billion | ₩404.37 Million | ▲ +139.8% |
| 2012 | 0.12x | ₩6.51 Billion | ₩805.15 Million | ▲ +102.1% |
| 2011 | 0.06x | ₩6.67 Billion | ₩408.49 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow